EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas-Reference-Cited by-同舟云学术

EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas

Published:2020-03 Issue: Volume:119 Page:35-45
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Otsuka Yasuyuki,Nishikori Momoko,Arima Hiroshi,Izumi Kiyotaka,Kitawaki Toshio,Hishizawa Masakatsu,Takaori-Kondo Akifumi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference48 articles.

1. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells;Altomonte;Cancer Res.,1993

2. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma;Ansell;N. Engl. J. Med.,2015

3. Nivolumab for Relapsed/Refractory diffuse large B-Cell lymphoma in patients ineligible for or having failed autologous transplantation: a single-arm, phase II study;Ansell;J. Clin. Oncol.,2019

4. Nivolumab for Relapsed/Refractory classic hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial;Armand;J. Clin. Oncol.,2018

5. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation;Beguelin;Cancer Cell,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma;Journal of Blood Medicine;2024-09

2. Recent advances in understanding the biology of follicular lymphoma;International Journal of Hematology;2024-03-27

3. CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma;Cancer Research;2024

4. Anti-CD20 antibody treatment for diffuse large B cell lymphoma: Genetic alterations and signaling pathways;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

5. Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities;Frontiers in Immunology;2023-11-02